↓ Skip to main content

Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults…

Overview of attention for article published in Neurocritical Care, July 2018
Altmetric Badge

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
73 Mendeley
Title
Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]
Published in
Neurocritical Care, July 2018
DOI 10.1007/s12028-018-0575-z
Pubmed ID
Authors

Daniel Hänggi, Nima Etminan, Stephan A. Mayer, E. Francois Aldrich, Michael N. Diringer, Erich Schmutzhard, Herbert J. Faleck, David Ng, Benjamin R. Saville, R. Loch Macdonald, for the NEWTON Investigators

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 19%
Student > Master 7 10%
Student > Bachelor 6 8%
Professor 5 7%
Student > Doctoral Student 4 5%
Other 15 21%
Unknown 22 30%
Readers by discipline Count As %
Medicine and Dentistry 19 26%
Neuroscience 9 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Nursing and Health Professions 3 4%
Agricultural and Biological Sciences 2 3%
Other 7 10%
Unknown 28 38%